SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002692
Filing Date
2019-04-29
Accepted
2019-04-29 16:45:28
Documents
4
Period of Report
2019-06-17
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238597zdef14a.htm DEF 14A 521275
2 G507891.JPG g507891.jpg GRAPHIC 16711
3 G25792BGI001.GIF g25792bgi001.gif GRAPHIC 93464
4 G25792BGI002.GIF g25792bgi002.gif GRAPHIC 168883
  Complete submission text file 0001047469-19-002692.txt   907049
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36020 | Film No.: 19776581
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1